Value Fund L. P. Biotechnology serves as Executive at AEOLUS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Value Fund L. P. Biotechnology has executed 256 insider transactions totaling $352.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 9, 2008 involved purchasing 29,700 shares valued at $127.4K.
Value Fund L. P. Biotechnology currently holds 4,058,854 shares of AEOLUS PHARMACEUTICALS, INC. (AOLS.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Value Fund L. P. Biotechnology has been a net seller of AOLS.OB stock. They have purchased $83.9M and sold $268.8M worth of shares.
Value Fund L. P. Biotechnology's most recent insider trade was on Jan 9, 2008, when they purchased 29,700 shares at $4.29 per share.
Get notified when new Form 4 filings are submitted
| $4.29 |
| Discretionary |
| Jan 9, 2008 | ARQL | $308.9K | Purchase | 72,000 | $4.29 | Discretionary |
| Jun 6, 2006 | AOLS.OB | $74.0K | Conversion | 148,000 | $0.50 | Discretionary |
| Jun 6, 2006 | AOLS.OB | $48.0K | Conversion | 96,000 | $0.50 | Discretionary |
| Jun 6, 2006 | AOLS.OB | $115.7K | Conversion | 231,328 | $0.50 | Discretionary |